Medication info
Tenelin M Extended-Release Tablet 10/750 mg

Tenelin M Extended-Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
Yellow oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201495 · Approved 2022.04.08 · Insurance code 662504770

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and dosage adjustments should be made as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from another glucose-lowering medicine. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes mellitus should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication helps patients with type 2 diabetes manage their blood sugar more effectively. It is used to provide additional therapeutic effects for those who are following dietary and exercise regimens, enabling stable blood sugar management. The combination of teneligliptin and metformin is particularly effective in improving blood sugar levels. This medication also contributes to the prevention of diabetic complications through sustained blood sugar control, thus assisting in the management of blood sugar in patients with type 2 diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and dosage adjustments should be made as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from another glucose-lowering medicine. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes mellitus should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication assists in controlling blood sugar levels. However, it may rarely cause a serious condition known as lactic acidosis, so caution is necessary. It should not be used in patients with poor kidney function, heart disease, or liver dysfunction. Additionally, treatment should be temporarily halted if undergoing surgery or experiencing severe infections, and should be restarted only after kidney function has recovered. The risk of hypoglycemia may increase when this medication is used in conjunction with other blood glucose-lowering agents, so it is important to be aware of symptoms of hypoglycemia. Regular monitoring of liver and kidney function during treatment is crucial, as well as checking vitamin B12 levels. Pregnant women or those who may become pregnant should not take this medication, and it is also not recommended for nursing mothers. The safety of this medication in children has not been established, and dosage adjustment may be necessary for the elderly based on kidney function. In case of overdose, immediate medical attention should be sought. Lastly, this medication should be kept out of the reach of children and should not be transferred to other containers.

Side effects

Severe lactic acidosis, hypoglycemia, constipation, bowel obstruction, liver dysfunction, interstitial pneumonia, dermatitis herpetiformis, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colon polyps, duodenal ulcer, gastroesophageal reflux disease, diarrhea, decreased appetite, elevated amylase, elevated lipase, elevated AST(GOT), elevated ALT(GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, pruritus, allergic dermatitis, arthralgia, elevated CK(CPK), elevated serum potassium levels, fatigue, allergic rhinitis, elevated serum uric acid levels, peripheral edema, shingles, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremors, headache, asthenia, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, cold sweat, diabetic retinopathy, decreased vision, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, cerebral infarction, diabetic neuropathy, paresthesia, diabetic neuropathy, spinal brainstem insufficiency, muscle weakness, back pain, limb pain, lumbar spinal stenosis, tendonitis, neck pain, bone pain, osteoarthritis, osteoporosis, muscle cramps, foot deformity, hypertrophic osteoarthritis, bursitis, spinal osteoarthritis, intervertebral disc protrusion, intervertebral disc disorder, spinal ligament ossification, spinal foraminal stenosis, postmenopausal osteoporosis, rotator cuff syndrome, gastritis, influenza, uterine suppuration, subcutaneous abscess, gastritis, vomiting, abdominal pain, gastrointestinal motility disorder, gastrointestinal motility reduction, enteritis, dental pain, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, iliac artery stenosis, bleeding, chest discomfort, fever, chills, systemic edema, injection site inflammation, chest pain, ureteral stones, bladder mass, dysuria, renal cysts, nocturia, urinary stones, depression, anxiety disorders due to general medical conditions, ovarian cysts, vulvar pruritus, menopausal symptoms, bile duct obstruction, toxic hepatitis, chronic cholecystitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid damage, ligament sprain, lip damage, contusion, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, vertigo, iron deficiency anemia, food allergy, pressure ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. The suitable storage temperature is room temperature between 1 to 30 degrees Celsius. Proper storage maintains the effectiveness of the medication.

Appearance and packaging

Appearance

Yellow oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.